This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Annane, D. Articles by Gajdos, P. Search for Related Content PubMed PubMed Citation Articles by Annane, D. Articles by Gajdos, P.

Circulation, Vol 90, 2629-2634, Copyright © 1994 by American Heart Association

ARTICLES

Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy

D Annane, D Duboc, B Mazoyer, P Merlet, M Fiorelli, B Eymard, H Radvanyi, C Junien, M Fardeau and P Gajdos
Service Hospitalier Frederic Joliot, CEA, Orsay, France.

BACKGROUND: Myotonic dystrophy, the most common form of adult dystrophy, has been shown to be caused by amplification of CTG triplet repeat in the 3' untranslated region of a protein kinase gene located on chromosome 19. Impaired glucose metabolism has been suggested as a possible explanation of brain and skeletal muscle involvement in this multisystem disease. We investigated whether myocardial glucose metabolism is impaired in myotonic dystrophy and whether this impairment is related to the size of the mutation. METHODS AND RESULTS: The myocardial metabolic rate for glucose (MMRGlu, mumol.min-1.g-1), K1 (blood-to-tissue transfer constant), k2 (tissue-to-blood transfer constant), and k3 (phosphorylation rate constant) were determined in 7 control subjects and 12 patients with myotonic dystrophy by using parametric images generated from dynamic cardiac positron emission tomography (PET) and 18F-fluoro-2-deoxy-glucose studies. The expansion of the CTG triplet repeats was analyzed in patients with the probe cDNA25 after EcoRI digestion. Nonparametric tests were used to compare quantitative variables between control subjects and patients. The correlations between the size of the mutation and PET parameters were studied by linear regression. MMRGlu and k3 were significantly decreased in patients compared with control subjects (0.39 +/- 0.20 versus 0.64 +/- 0.25, P = .03, and 0.09 +/- 0.07 versus 0.24 +/- 0.21, P = .03, respectively), whereas K1 and k2 were not statistically different between control subjects and patients. MMRGlu and k3 correlate inversely with the length of the CTG triplet repeat (r = -.65 and P = .03 for MMRGlu, and r = -.85 and P = .001 for k3, respectively). CONCLUSIONS: In myotonic dystrophy, the observed reductions in MMRGlu and phosphorylation are inversely linked to the length of the mutation. This observation suggests that impaired modulation of a protein kinase involved in myocardial hexokinase activation may give a pathophysiological schema to relate the molecular defect and the abnormal myocardial metabolism in myotonic dystrophy.

This article has been cited by other articles:

				G. Perseghin, M. Comola, P. Scifo, S. Benedini, F. De Cobelli, R. Lanzi, F. Costantino, G. Lattuada, A. Battezzati, A. Del Maschio, et al. Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1 Am. J. Clinical Nutrition, August 1, 2004; 80(2): 357 - 364. [Abstract] [Full Text] [PDF]

				G. Perseghin, A. Caumo, C. Arcelloni, S. Benedini, R. Lanzi, E. Pagliato, L. P. Sereni, G. Testolin, A. Battezzati, G. Comi, et al. Contribution of Abnormal Insulin Secretion and Insulin Resistance to the Pathogenesis of Type 2 Diabetes in Myotonic Dystrophy Diabetes Care, July 1, 2003; 26(7): 2112 - 2118. [Abstract] [Full Text] [PDF]

				Q. Liang, R. V Donthi, P. M Kralik, and P. N Epstein Elevated hexokinase increases cardiac glycolysis in transgenic mice Cardiovasc Res, February 1, 2002; 53(2): 423 - 430. [Abstract] [Full Text] [PDF]

				D Babuty, L Fauchier, D Tena-Carbi, P Poret, J Leche, M Raynaud, J P Fauchier, and P Cosnay Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods? Heart, November 1, 1999; 82(5): 634 - 637. [Abstract] [Full Text]

				A. Lazarus, J. Varin, Z. Ounnoughene, H. Radvanyi, C. Junien, J. Coste, P. Laforet, B. Eymard, H. M. Becane, S. Weber, et al. Relationships Among Electrophysiological Findings and Clinical Status, Heart Function, and Extent of DNA Mutation in Myotonic Dystrophy Circulation, March 2, 1999; 99(8): 1041 - 1046. [Abstract] [Full Text] [PDF]

				D. Annane, P. Merlet, H. Radvanyi, B. Mazoyer, B. Eymard, M. Fiorelli, C. Junien, M. Fardeau, Z. Ounnoughene, P. Gajdos, et al. Blunted Coronary Reserve in Myotonic Dystrophy An Early and Gene-Related Phenomenon: An Early and Gene-Related Phenomenon Circulation, September 1, 1996; 94(5): 973 - 977. [Abstract] [Full Text]

				M. Maeda, C. S. Taft, E. W. Bush, E. Holder, W. M. Bailey, H. Neville, M. B. Perryman, and R. D. Bies Identification, Tissue-specific Expression, and Subcellular Localization of the 80- and 71-kDa Forms of Myotonic Dystrophy Kinase Protein J. Biol. Chem., September 1, 1995; 270(35): 20246 - 20249. [Abstract] [Full Text] [PDF]